Abstract
Aim . Study of possible problems of online sales of pharmaceutical goods in the Republic of Kazakhstan and identification of the main reasons for their occurrence. Materials and methods . Databases of the Information System of Labeling and Traceability of Goods (markirovka.ismet.kz) for studying the unified scheme of turnover of pharmaceutical goods, the Information and Legal System of Regulatory Legal Acts of the Republic of Kazakhstan (Adilet.zan.kz) for analysis of regulatory documents in the field of circulation of medicines and medical devices of the Republic of Kazakhstan, as well as official websites of state bodies of the Republic of Kazakhstan, RSCI, Scopus, Pubmed databases. Results and discussion. A comparative analysis of the pharmaceutical e-commerce market in the Republic of Kazakhstan was carried out, focused on the retail sale of medicines. In addition, a comparative analysis of the obtained data with the database of regulatory legal acts of the Republic of Kazakhstan was carried out. As a result, the main problems arising in the sale of medicines through online platforms, such as online pharmacies and marketplaces, were identified. Conclusions . Online sale of medicines in Kazakhstan is associated with many problems related to quality control, compliance with regulatory requirements and maintaining the confidentiality of buyers' data. The main risks include difficulties in checking permits, control of the authenticity and quality of products, violation of storage and transportation conditions, as well as problems with the return of goods and price regulation. In addition, significant attention is required to ensure the security of patient data and the accuracy of the translation of information about products.